Need Help?

RNAseq of mCRC xenografts under cetuximab treatment, placebo or after treatment release

Determine if cetuximab treatment selects any pre-existing resistant subclones or if the resistant cells, which in vivo determines residual disease, are driven by plasticity effects not linked to mutations.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001005185 Illumina HiSeq 2500 9